drugset / Trial / NCT02583009
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical study is to determine the optimum dose of PAC-14028 cream in a therapeutic confirmatory clinical study by evaluating the safety and therapeutic equivalence of PAC-14028 cream 0.1%, 0.3% and 1.0% in patients with rosacea.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PAC-14028 | Unknown | 0.1 % | Topical |
| Subject | PAC-14028 | Unknown | 0.3 % | Topical |
| Subject | PAC-14028 | Unknown | 1 % | Topical |